We are international
Donate
• videos TEXT SIZE   
imf international webcasts

Dr. Richardson - Final Results of a Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Patients with Advanced Multiple Myeloma
Paul Richardson, MD
Jerome Lipper Myeloma Center
Dana Farber Cancer Institute
Boston, MA
Member, IMF Board of Scientific Advisors
01.01.08


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles